NIBP Study for Neonate and Pediatric Subject Populations
← catalyst calendarNCT07684885 · readout in 134 d
Sponsored by GE Healthcare (industry) · GEHC — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · None · Diagnostic
Enrollment
110estimated
Sites
2
Country
Finland
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-05-14 | actual | When the study began enrolling |
| Primary completion | 2026-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2026-07-06 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Blood Pressure
- Blood Pressure Measurement
Intervention
- Device: NIBP Measurement
Primary outcome
what the primary-completion date above is the date OFPrimary Outcome Measure
measured Up to 12 hours from time of study procedure start
Permalink · GEHC's whole pipeline · Catalyst calendar · Every registered study · What changed